Hypertrophic cardiomyopathy (HCM) is the most common inherited myocardial disease and characterized by extreme clinical and genetic heterogeneity. Information on the prognostic value of genotype is currently limited. In this thesis, we compared the clinical phenotype and outcome of genotype-positive and genotype-negative patients with HCM during long-term follow-up; genotype-positive status was an independent risk factor of mortality. In addition, we analyzed the clinical findings and outcome in patients with Dutch Myosin-Binding Protein C founder mutations and found no difference in compariso
Genetic testing for hypertrophic cardiomyopathy (HCM) is an established clinical technique, supporte...
This article aims to show clearly, especially to cardio-logists, the currently recognized genetic mu...
BackgroundHypertrophic cardiomyopathy (HCM) is the most common inherited cardiovascular disease that...
Hypertrophic cardiomyopathy (HCM), in contrast to common prejudications, has been recognized as the ...
© 2018 Elsevier B.V. All rights reserved.Background: We present an ancillary study of the Portuguese...
Introduction: Hypertrophic cardiomyopathy (HCM) is characterised by marked heterogeneity both in phe...
Knowledge on the influence of specific genotypes on the phenotypic expression of hypertrophic cardio...
Hypertrophic cardiomyopathy (HCM) is an inherited disorder of cardiac muscle whose genetic basis has...
Over the last 2 decades, the pathogenic basis for the most common heritable cardiovascular disease, ...
Background: Hypertrophic cardiomyopathy (HCM) is caused by rare variants in sarcomere-encoding genes...
Hypertrophic cardiomyopathy (HCM) is the most common familial heart disease with vast genetic hetero...
Hypertrophic cardiomyopathy (HCM) is the most common inheritable cardiac disorder with a phenotypic ...
Aims: This study sought to determine the usefulness of genetic testing to predict evolution in hyper...
Hypertrophic cardiomyopathy (HCM) is most commonly transmitted as an autosomal dominant trait, cause...
Background: A better understanding of the factors that contribute to heterogeneous outcomes and life...
Genetic testing for hypertrophic cardiomyopathy (HCM) is an established clinical technique, supporte...
This article aims to show clearly, especially to cardio-logists, the currently recognized genetic mu...
BackgroundHypertrophic cardiomyopathy (HCM) is the most common inherited cardiovascular disease that...
Hypertrophic cardiomyopathy (HCM), in contrast to common prejudications, has been recognized as the ...
© 2018 Elsevier B.V. All rights reserved.Background: We present an ancillary study of the Portuguese...
Introduction: Hypertrophic cardiomyopathy (HCM) is characterised by marked heterogeneity both in phe...
Knowledge on the influence of specific genotypes on the phenotypic expression of hypertrophic cardio...
Hypertrophic cardiomyopathy (HCM) is an inherited disorder of cardiac muscle whose genetic basis has...
Over the last 2 decades, the pathogenic basis for the most common heritable cardiovascular disease, ...
Background: Hypertrophic cardiomyopathy (HCM) is caused by rare variants in sarcomere-encoding genes...
Hypertrophic cardiomyopathy (HCM) is the most common familial heart disease with vast genetic hetero...
Hypertrophic cardiomyopathy (HCM) is the most common inheritable cardiac disorder with a phenotypic ...
Aims: This study sought to determine the usefulness of genetic testing to predict evolution in hyper...
Hypertrophic cardiomyopathy (HCM) is most commonly transmitted as an autosomal dominant trait, cause...
Background: A better understanding of the factors that contribute to heterogeneous outcomes and life...
Genetic testing for hypertrophic cardiomyopathy (HCM) is an established clinical technique, supporte...
This article aims to show clearly, especially to cardio-logists, the currently recognized genetic mu...
BackgroundHypertrophic cardiomyopathy (HCM) is the most common inherited cardiovascular disease that...